Fundraising Fox
ELIAS Animal Health
Olathe, US · Founded 2014 · Delaware LLC · 9 employees on LinkedIn
Find your way into ELIAS Animal Health
Sign up to see every warm intro you have to ELIAS Animal Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ELIAS Animal Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ELIAS Animal Health develops ELIAS Cancer Immunotherapy (ECI®), a personalized cancer treatment for dogs that combines an autologous vaccine with adoptive T cell therapy to target a patient's own cancer cells. The USDA-approved treatment for canine bone cancer is delivered through veterinarians and veterinary hospitals at authorized treatment centers across the United States.
Founders & leadership
ELIAS Animal Health was founded in 2014 by Tammie A. Wahaus.
TA
Tammie A. WahausFounder, Chief Executive Officer and Board ChairTammie A. Wahaus is a business and financial executive with experience in strategic planning, financing, M&A, and compliance across biotechnology, telecommunications, financial services, and other industries, including advisory work with Fortune 100 companies.
Board
CB
Charles BurtonBoard director
CS
Chuck StephensBoard director
GW
Gary WoodBoard director
LM
Larry MaddoxBoard director
MP
Mark PattersonBoard director
Reported raises · per SEC filings
Form D private placements$3.4M disclosed across 3 rounds · 2014–2017
▶$714.3KraisedMay 2017 · 10 investors · BiotechnologyRule 506(b)
▶$714.3KraisedMay 2017 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles BurtonDirector
- Chuck StephensDirector
- Tammie A. WahausExecutive Officer, Director
- Gary WoodDirector
- Mark PattersonDirector
- Larry MaddoxDirector
- Offering amount
- $800K
- Amount sold
- $714.3K
- Minimum investment
- $25K
- First sale
- Apr 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$650.1KraisedJul 2016 · 14 investors · BiotechnologyRule 506(b)
▶$650.1KraisedJul 2016 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chuck StephensDirector
- Gary WoodExecutive Officer
- Larry MaddoxDirector
- Tammie A. WahausExecutive Officer, Director
- Charles BurtonDirector
- Mark PattersonDirector
- Offering amount
- $1M
- Amount sold
- $650.1K
- First sale
- Jun 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$2MraisedApr 2015 · 42 investors · BiotechnologyRule 506(b)
▶$2MraisedApr 2015 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles BurtonDirector
- Tammie A. WahausExecutive Officer
- Chuck StephensDirector
- Gary WoodDirector
- Larry MaddoxDirector
- Mark PattersonDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Nov 2014
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
ImpriMedImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
VcahospitalsVCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.
Dvm360dvm360 is a veterinary medicine news and education publisher, delivering clinical articles, video shorts, continuing education, and conference coverage for veterinarians, technicians, and practice staff. It also produces a digital edition and reports on industry developments across the veterinary profession.
Petcure OncologyPetCure Oncology, founded in 2014, operates a network of veterinary cancer care centers offering stereotactic radiation therapy (SRS/SRT) and other cancer treatments for pets. It serves pet owners in the U.S. seeking advanced radiation oncology options for animals with cancer.
Companies working in the same space as ELIAS Animal Health.
In the news
Frequently asked questions
- What does ELIAS Animal Health do?
- ELIAS Animal Health develops ELIAS Cancer Immunotherapy (ECI®), a personalized cancer treatment for dogs that combines an autologous vaccine with adoptive T cell therapy to target a patient's own cancer cells. The USDA-approved treatment for canine bone cancer is delivered through veterinarians and veterinary hospitals at authorized treatment centers across the United States.
- Who founded ELIAS Animal Health?
- ELIAS Animal Health was founded by Tammie A. Wahaus in 2014.
- How much funding has ELIAS Animal Health raised?
- ELIAS Animal Health has disclosed $3.4M raised across 3 rounds.
- Where is ELIAS Animal Health headquartered?
- ELIAS Animal Health is headquartered in Olathe, US.